Avidity Biosciences Stock Technical Analysis
| RNA Stock | USD 72.64 0.01 0.01% |
As of the 27th of January, Avidity Biosciences shows the Mean Deviation of 0.165, coefficient of variation of 376.27, and Risk Adjusted Performance of 0.1773. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avidity Biosciences, as well as the relationship between them.
Avidity Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Avidity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AvidityAvidity Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Avidity Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avidity Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avidity Biosciences.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Avidity Biosciences on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Avidity Biosciences or generate 0.0% return on investment in Avidity Biosciences over 90 days. Avidity Biosciences is related to or competes with Jazz Pharmaceuticals, Madrigal Pharmaceuticals, Caris Life, Moderna, Abivax SA, Cytokinetics, and Nuvalent. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies More
Avidity Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avidity Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avidity Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1962 | |||
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 1.75 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.3757 |
Avidity Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avidity Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avidity Biosciences' standard deviation. In reality, there are many statistical measures that can use Avidity Biosciences historical prices to predict the future Avidity Biosciences' volatility.| Risk Adjusted Performance | 0.1773 | |||
| Jensen Alpha | 0.0505 | |||
| Total Risk Alpha | 0.0348 | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | 0.4685 |
Avidity Biosciences January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1773 | |||
| Market Risk Adjusted Performance | 0.4785 | |||
| Mean Deviation | 0.165 | |||
| Downside Deviation | 0.1962 | |||
| Coefficient Of Variation | 376.27 | |||
| Standard Deviation | 0.2606 | |||
| Variance | 0.0679 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | 0.0505 | |||
| Total Risk Alpha | 0.0348 | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | 0.4685 | |||
| Maximum Drawdown | 1.75 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.3757 | |||
| Downside Variance | 0.0385 | |||
| Semi Variance | (0.05) | |||
| Expected Short fall | (0.20) | |||
| Skewness | 1.75 | |||
| Kurtosis | 7.38 |
Avidity Biosciences Backtested Returns
At this point, Avidity Biosciences is very steady. Avidity Biosciences secures Sharpe Ratio (or Efficiency) of 0.27, which signifies that the company had a 0.27 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Avidity Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Avidity Biosciences' Mean Deviation of 0.165, risk adjusted performance of 0.1773, and Coefficient Of Variation of 376.27 to double-check if the risk estimate we provide is consistent with the expected return of 0.0693%. Avidity Biosciences has a performance score of 21 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Avidity Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Avidity Biosciences is expected to be smaller as well. Avidity Biosciences right now shows a risk of 0.26%. Please confirm Avidity Biosciences treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to decide if Avidity Biosciences will be following its price patterns.
Auto-correlation | 0.81 |
Very good predictability
Avidity Biosciences has very good predictability. Overlapping area represents the amount of predictability between Avidity Biosciences time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avidity Biosciences price movement. The serial correlation of 0.81 indicates that around 81.0% of current Avidity Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.81 | |
| Spearman Rank Test | 0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Avidity Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Avidity Biosciences Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Avidity Biosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Avidity Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Avidity Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Avidity Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Avidity Biosciences price pattern first instead of the macroeconomic environment surrounding Avidity Biosciences. By analyzing Avidity Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Avidity Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Avidity Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
Avidity Biosciences January 27, 2026 Technical Indicators
Most technical analysis of Avidity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Avidity from various momentum indicators to cycle indicators. When you analyze Avidity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1773 | |||
| Market Risk Adjusted Performance | 0.4785 | |||
| Mean Deviation | 0.165 | |||
| Downside Deviation | 0.1962 | |||
| Coefficient Of Variation | 376.27 | |||
| Standard Deviation | 0.2606 | |||
| Variance | 0.0679 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | 0.0505 | |||
| Total Risk Alpha | 0.0348 | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | 0.4685 | |||
| Maximum Drawdown | 1.75 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.3757 | |||
| Downside Variance | 0.0385 | |||
| Semi Variance | (0.05) | |||
| Expected Short fall | (0.20) | |||
| Skewness | 1.75 | |||
| Kurtosis | 7.38 |
Avidity Biosciences January 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Avidity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 680.14 | ||
| Daily Balance Of Power | 0.10 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 72.61 | ||
| Day Typical Price | 72.62 | ||
| Price Action Indicator | 0.04 |
Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |